Publications

5803 Results

Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma

Authors
JV Tricoli;DG Blair;CK Anders;WA Bleyer;L Boardman;J Khan;S Kummar;B Hayes-Lattin;S Hunger;M Merchant;N Seibel;M Thurin;C Willman
Journal / Conference
Cancer Apr 1;122(7):1017-1028
Year
2016
Research Committee(s)
Cancer Care Delivery
PMID
PMID26849082
PMC
PMC4803597

Development and evaluation of an approach to using value of information analyses for real-time prioritization decisions within SWOG, a large cancer clinical trials cooperative group

Authors
CS Bennette;D Veenstra;A Basu;LH Baker;SD Ramsey;JJ Carlson
Journal / Conference
Medical Decision Making Jul;36(5):641-651
Year
2016
Research Committee(s)
Cancer Care Delivery
PMID
PMID27012232
PMC
PMC5963256

The role of clinical trial participation in cancer research: barriers, evidence, and strategies

Authors
JM Unger;ED Cook;E Tai;WA Bleyer
Journal / Conference
American Society of Clinical Oncology Educational Book 35:185-198
Year
2016
Research Committee(s)
Cancer Care Delivery
PMID
PMID27249699
PMC
PMC5495113

Measuring the real clinical impact of randomized clinical trials in oncology-reply: beyond citation counts [Comment and Response]

Authors
JM Unger;W Barlow;D Hershman
Journal / Conference
JAMA Oncology Nov 1;2(11):1511
Year
2016
Research Committee(s)
Cancer Care Delivery
PMID
PMID: 27355398
PMC
PMC n/a - Correspondence

Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: Alliance for Clinical Trials in Oncology Trial A021101

Authors
MHG Katz;Q Shi;SA Ahmad;JM Herman;R Marsh;E Collisson;L Schwartz;W Frankel;R Martin;W Conway;M Truty;H Kindler;AM Lowy;T Behaii-Saab;PA Philip;M Talamonti;D Cardin;N LoConte;P Chen;J Hoffman;AP Venook
Journal / Conference
JAMA Surgery Jun 8:e161137
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID27275632
PMC
PMC5210022
Study Number(s)
CTSU/A021101

Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database

Authors
D Papamichael;LA Renfro;C Matthaiou;G Yothers;L Saltz;KA Guthrie;E Van Cutsem;H Schmoll;R Labianca;T Andre;M O'Connell;SR Alberts;DG Haller;P Kountourakis;D Sargent
Journal / Conference
Journal of Geriatric Oncology 2016 Jul 25. pii: S1879-4068(16)30088-1. doi: 10.1016/j.jgo.2016.07.002 Jul 25 [Epub ahead of print]
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID27468630
PMC
PMC5159186
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Extending aromatase-inhibitor adjuvant therapy to 10 years

Authors
PE Goss;JN Ingle;KI Pritchard;NJ Robert;H Muss;J Gralow;K Gelmon;T Whelan;K Strasser Weippl;S Rubin;K Sturtz;AC Wolff;E Winer;C Hudis;A Stopeck;JT Beck;J Kaur;K Whelan;D Tu;WR Parulekar
Journal / Conference
New England Journal of Medicine Jul 21;375(3):209-219
Year
2016
Research Committee(s)
Breast
PMID
PMID27264120
PMC
PMC5024713
Study Number(s)
JMA17

A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)

Authors
C Zent;X Zang;RP Ketterling;C Hanson;E Libby;J Barrientos;T Call;J Call;JE Chang;JJ Liu;A Calvo;H Lazarus;J Rowe;S Luger;M Litzow;M Tallman
Journal / Conference
American Journal of Hematology Mar;91(3):308-312
Year
2016
Research Committee(s)
Leukemia
PMID
PMID26662208
PMC
PMC4806550
Study Number(s)
CTSU/E1908

Usage of Oregon’s Death with Dignity Act (DWDA)

Authors
C Blanke;M Leblanc;D Hershman;L Ellis;F Meyskens
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl 26S; abstr 44); ASCO Palliative Care in Oncology Symposium (Sept 9-10, 2016, San Francisco, CA), poster
Year
2016
Research Committee(s)
Cancer Care Delivery

Continued excellent outcomes in previously untreated follicular lymphoma patients after treatment with CHOP plus rituximab or CHOP plus (131) iodine-tositumomab - long term follow-up of phase III randomized study SWOG S0016

Authors
M Shadman;H Li;L Rimsza;JP Leonard;M Kaminski;R Braziel;C Spier;A Gopal;D Maloney;B Cheson;S Dakhil;M Leblanc;SM Smith;RI Fisher;JW Friedberg;O Press
Journal / Conference
Blood 128:616;American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), oral
Year
2016
Research Committee(s)
Lymphoma
Study Number(s)
S0016